Kelso Pharma

Kelso Pharma

Specialty pharmaceutical company focused on commercializing medical products and ensuring global market access.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
*

£70.0m

Debt
Total Funding000k
More about Kelso Pharma
Made with AI
Edit

Kelso Pharma Group operates in the pharmaceutical sector, focusing on the commercialization of pharmaceutical and medical device products. The company serves a global market, leveraging extensive experience in market access and commercial sales to launch and grow its product portfolio. Kelso Pharma's business model revolves around directing commercial sales and marketing operations, with a strong emphasis on compliance and ethical practices, including a zero-tolerance policy towards bribery and corruption. The company generates revenue through the successful launch and distribution of its products, aiming to expand its market presence and achieve sustainable growth. Key clients include healthcare providers and institutions that require specialized pharmaceutical solutions. Kelso Pharma's strategic gatherings, such as the recent all-company meeting in Edinburgh, highlight its commitment to collaboration and planning for future growth. Keywords: pharmaceutical, commercialization, medical devices, market access, global, compliance, sales, marketing, product launches, healthcare.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Investments by Kelso Pharma

Edit
Velit Biopharma
ACQUISITION by Kelso Pharma Nov 2023
Stirling Anglian Pharmaceuticals
ACQUISITION by Apposite Capital Jan 2022
Alturix
ACQUISITION by Kelso Pharma Feb 2025